Bio Path | BPTH - 营业利润





营业利润 更改 日
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Baxter International USD -214.2M 415.4M 2025-12
Bio Path USD -488K 4.07M 2025-09
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12